Tacalyx
PrivateLast Round
Seed
Apr 29, 2026
Total Funding Raised
$28M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Tacalyx operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Seed round in April 2026.
Tacalyx is a biotechnology company that develops novel anticancer therapeutics targeting Tumor Associated Carbohydrate Antigens (TACAs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tacalyx Comparables
Compare Tacalyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 86% | |
| 遠友ファーマ株式会社 | 84% | |
| TegMine Therapeutics | 81% |
For institutional investors. Book with your work email.
Tacalyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 29, 2026 | ||||
| Seed | Jun 11, 2024 | ||||
| Seed | Sep 25, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tacalyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Seed |
| Idinvest Partners | Seed |
| Eurazeo Investment Manager | Seed |
| Thuja Capital | Seed |
| Max Planck Society for the Advancement of Science | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| Creathor Venture | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 6960% MoM, from 10 to 706.
- Apr 29, 2026
$12M round with participation from Eurazeo and Boehringer Ingelheim.
For institutional investors. Book with your work email.
Tacalyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tacalyx's valuation, stock price, and market status.
Is Tacalyx a public or private company?
Tacalyx is a private company.
What is the current stock price of Tacalyx?
Tacalyx is a private company, so its shares have no public market price. Caplight tracks Tacalyx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tacalyx worth (valuation)?
Valuation information for Tacalyx is not publicly available.
Can I buy Tacalyx stock?
Tacalyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tacalyx's last funding round?
Tacalyx's most recent funding round was Seed on April 29, 2026.
Who are the main investors in Tacalyx?
Key investors in Tacalyx include Boehringer Ingelheim, Thuja Capital, Boehringer Ingelheim Venture Fund, Kurma Partners.
Will Tacalyx IPO soon?
No public IPO plans have been announced for Tacalyx.
How can I track Tacalyx secondary market activity?
Caplight tracks bids, offers, and trades in Tacalyx's shares on secondary markets.